Fresenius Kabi
Hortense de Saint Sernin is an accomplished finance professional with extensive experience in leadership roles within the finance sector. Currently serving as the VP and Head of Finance for Eastern Europe at Fresenius Kabi since December 2020, Hortense previously held several significant positions at Subsea 7 from August 2008 to December 2020, including Finance Manager, F P&A Manager for the Africa region, and Tax Reporting Analyst for the AFMED Region. Hortense's early career involved a role as a Senior Auditor at Mazars. Academic qualifications include a Maitrise des Sciences de Gestion with a specialization in Finance and Taxation from Université Paris Dauphine, alongside financial accounting and tax law degrees from The University of Kansas and Université Bourgogne Europe.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.